Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.

Itazawa T, Adachi Y, Ito Y, Higuchi O, Mochizuki H, Shimojo N, Inoue T.

Allergol Int. 2013 Mar;62(1):131-5. doi: 10.2332/allergolint.12-OA-0482. Epub 2013 Jan 25.

2.

Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.

Akapo S, Gupta J, Martinez E, McCrea C, Ye L, Roach M.

Ann Pharmacother. 2008 Oct;42(10):1416-24. doi: 10.1345/aph.1L273.

PMID:
18780805
3.

Compatibility of budesonide inhalation suspension with four nebulizing solutions.

McKenzie JE, Cruz-Rivera M.

Ann Pharmacother. 2004 Jun;38(6):967-72. Epub 2004 Apr 14.

PMID:
15084687
4.

Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.

Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B.

Pediatrics. 2003 Sep;112(3 Pt 1):e212-9.

PMID:
12949315
6.

Medical nebulizer performance: effects of cascade impactor temperature.

Zhou Y, Ahuja A, Irvin CM, Kracko DA, McDonald JD, Cheng YS.

Respir Care. 2005 Aug;50(8):1077-82.

7.

Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.

Vogelmeier C, Naya I, Ekelund J.

Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.

PMID:
22607479
8.

Evaluation of nebulizer performance under various humidity conditions.

Zhou Y, Ahuja A, Irvin CM, Kracko D, McDonald JD, Cheng YS.

J Aerosol Med. 2005 Fall;18(3):283-93.

PMID:
16181003
9.

Droplet aerodynamics, cellular uptake, and efficacy of a nebulizable corticosteroid nanosuspension are superior to a micronized dosage form.

Britland S, Finter W, Chrystyn H, Eagland D, Abdelrahim ME.

Biotechnol Prog. 2012 Sep-Oct;28(5):1152-9. doi: 10.1002/btpr.1616. Epub 2012 Sep 21.

PMID:
22887984
10.

Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.

Zhou Y, Brasel TL, Kracko D, Cheng YS, Ahuja A, Norenberg JP, Kelly HW.

Pharm Dev Technol. 2007;12(4):353-9.

PMID:
17763140
11.

The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.

Nikander K, Turpeinen M, Wollmer P.

J Aerosol Med. 1999 Summer;12(2):47-53.

PMID:
10539706
12.

Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma.

Szefler SJ, Eigen H.

J Allergy Clin Immunol. 2002 Apr;109(4):730-42. Review.

PMID:
11941331
13.
14.

Systemic availability and lung deposition of budesonide via three different nebulizers in adults.

Dahlström K, Thorsson L, Larsson P, Nikander K.

Ann Allergy Asthma Immunol. 2003 Feb;90(2):226-32.

PMID:
12602671
15.

Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.

Kamin W, Schwabe A, Krämer I.

J Cyst Fibros. 2006 Dec;5(4):205-13. Epub 2006 May 5. Review.

16.

Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycin.

Klemmer A, Krämer I, Kamin W.

Pulm Pharmacol Ther. 2014 Jun;28(1):53-9. doi: 10.1016/j.pupt.2013.08.003. Epub 2013 Sep 10.

PMID:
24035821
17.

Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.

Leflein JG, Szefler SJ, Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Smith JA.

Pediatrics. 2002 May;109(5):866-72.

PMID:
11986448
18.

Aerodynamic and electrostatic properties of model dry powder aerosols: a comprehensive study of formulation factors.

Telko MJ, Hickey AJ.

AAPS PharmSciTech. 2014 Dec;15(6):1378-97. doi: 10.1208/s12249-014-0144-5. Epub 2014 Jun 18.

19.

[Therapy with nebulized beta2 agonists (procaterol) in asthmatic children: pulmonary function and plasma levels after inhalation].

Kishida M, Nakazono H, Kuroiwa R, Dokai H, Nakazato J, Nakamura H, Suzuki I, Shinomiya N.

Arerugi. 2007 Nov;56(11):1372-7. Japanese.

PMID:
18059150
20.

Airway and systemic effects of soluble and suspension formulations of nebulized budesonide in asthmatic children.

Basu K, Nair A, Williamson PA, Mukhopadhyay S, Lipworth BJ.

Ann Allergy Asthma Immunol. 2009 Nov;103(5):436-41. doi: 10.1016/S1081-1206(10)60365-1.

PMID:
19927544

Supplemental Content

Support Center